Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data

In this study we looked at clinical outcomes of patients who underwent cardioversion in the non-interventional Global Anticoagulant Registry in the FIELD-AF (GARFIELD-AF). 44 201 patients were included in an analysis comparing patients who received a baseline cardioversion with those who did not (two years follow-up), and 7175 patients were included in an analysis comparing patients who received direct current cardioversion and those who had pharmacological cardioversion throughout the study time (one year follow-up).
       We found that a small proportion were treated with a baseline cardioversion (14.9%). Direct current cardioversion was performed twice as often as pharmacological cardioversion, and there appeared to be no major difference in outcome events for these two cardioversion modalities. For the overall cardioversion group, after adjustments for confounders, a significantly lower risk of mortality was found in patients who received cardioversion at baseline compared with those who did not (propensity score weighted HR 0.74 (95% CI 0.63-0.86) from baseline to one year follow-up and 0.77 (0.64-0.93) from one year to two year follow-up). Read more.

Pope MK, Hall TS, Schirripa V, Radic P, Virdone S, Pieper KS, Le Heuzey JY, Jansky P, Fitzmaurice DA, Cappato R, Atar D, Camm AJ, Kakkar AK; GARFIELD-AF investigators.



Categories: NEWS

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: